
Astanor leads series-A round for Hyris
Astanor Ventures has led a series-A funding round for biotechnology startup Hyris.
The funding round is said to have raised €2.5m for the company. The round was oversubscribed, according to a statement.
Astanor is an impact investor in the agriculture technology sector. Italian investors, including Neos Medica, IDB Holding – the holding company controlling Indena – and Pi Campus also participated.
The capital will go towards sales and marketing of the product.
Company
Based in London and founded in 2014, Hyris offers DNA testing for food quality assurance.
People
Astantor Ventures – George Coelho (co-founder, partner).
Hyris – Stefano Lo Priore (founder, CEO).
Advisers
Equity – Withers Worldwide (legal).
Company – Cross Border Growth Capital, Fabio Mondini de Focatiis (corporate finance); TLT (legal); Legance (legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater